TO STUDY CHANGES IN VASCULAR WALL STIFFNESS IN OBESE PATIENTS WITH PAROXYSMAL AF DURING THE PERIOD OF SINUS RHYTHM PRESERVATION
Keywords:
chronic heart failure, inflammatory heart diseases, body weight.Abstract
Obesity is a growing epidemic, with its prevalence doubling in the past 30 years. Overweight is considered as an independent risk factor for the development of arterial hypertension( AH), diabetes mellitus, coronary heart disease, and chronic heart failure.
References
Wong C.X., Sullivan T., Sun M.T., et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clinical Electrophysiology. 2015;1:139-52. DOI:10.1016/j.jacep.2015.04.004.
Podzolkov V.I., Tarzimanova A.I., Gataulin R.G., et al. the Role of obesity in the development of atrial fibrillation: the current state of the problem. Cardiovascular Therapy and Prevention. 2019;18(4):109- 14 (In Russ.) [Podzolkov V..I., Tarzimanova A..I., Gataulin R..G., et al.. The role of obesity in the development of atrial fibrillation: current state of the problem. Cardiovascular Therapy and Prevention. 2019;18(4):109-14]. DOI:10.15829/1728-8800-2019-4-109-114.
Goudis C.A., Korantzopoulos P., Ntalas I.V., et al. Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links. J Cardiol. 2015;66(5):361-9. DOI:10.1016/ j.jjcc.2015.04.002.
Kotsis V., Stabouli S., Papakatsika S., et al. Mechanisms of obesity-induced hypertension. Hypertens Res. 2010;33(5):386-93. DOI:10.1038/hr.2010.9.
Ogunsua A.A., Shaikh A.Y., Ahmed M., McManus D.D. Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels. Methodist DebakeyCardiovasc J. 2015;11(4):228-34. DOI:10.14797/mdcj-11-4-228.
Yang T., Yang P., Roden D.M., Darbar D. Novel KCNA5 mutation implicates tyrosine kinase sig naling in human atrial fibrillation. Heart Rhythm. 2010;7(9):1246-52. DOI:10.1016/j.hrthm.2010.05.032.
Lumeng C.N., DelProposto J.B., Westcott D.J., et al. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes. 2008;57(12):3239-46. DOI:10.2337/db08-0872.
Zaripova D. Ya., Negmatullayeva M. N., Tuksanova D. I. The role of Aleandronic acid (Ostalon) in the treatment of perimenopausal osteoporosis. Dr. akhborotnomasi 2019; 4(3) pages23-27.
Zaripova D. Ya., Negmatullayeva M. N., Tuksanova D. I., Ashurova N. G. Influence of magnesium deficiency state and imbalance of steroid hormones in the vital activity of a woman's body. Tibbietda yangi kun. №4.2019 p. 45-49.
